Science Market Update

$2M NIH Life Science Grant for UCSF Kidney Transplant Research Program

Posted by Gloria Beverage on Tue, May 29, 2018

University of California San Francisco recently received a $2,370,047 grant from the National Institutes of Health(NIH). This is the fourth year that funding has been allocated for a $17 million multi-center study to improve long-term survival of kidney transplant recipients. 

The goal is to reduce or eliminate inflammation in kidney transplant patients and prevent decline in function. The study involves two clinical trials and simultaneous research by biologists and researchers.

Read More

Tags: University of California San Francisco, sell lab products, clinical trials, SFVS, UCSF, laboratory equipment suppliers, Lab Product Sales, UC San Francisco Parnassus, kidney research, UCSF Mission Bay, BioResearch Product Faire, nih research funding

University of Illinois Research News: Synthetic Cannabiniod Reduces Sleep Apnea

Posted by Rebecca Inch-Partridge on Thu, Jan 04, 2018

When obstructive sleep apnea (OSA) was listed as a contributing factor in the death of actress Carrie Fisher, it brought the condition into the spotlight. Until the news, many people considered sleep apnea to be just a bothersome form of snoring. However, with OSA, breathing is actually interrupted for a few seconds or even several minutes. According to the American sleep apnea association, 38,000 people die annually from heart disease directly complicated by sleep apnea. Now researchers at the University of Illinois, Chicago (UIC) believe they have found the first medication that reduces the effects of OSA, and it's  based on a molecule found in the cannabis plant.

Read More

Tags: Bioresearch, Bioresearch funding, University of Illinois, Cannabinoids, University of Illinois Chicago, Illinois, University of Illinois at Chicago, clinical trials, Chicago, biotech vendor show, laboratory equipment suppliers, research news, UIC, UIChgo, laboratory suppliers, BioResearch Product Faire, cannabis research

UCSF: New MS Therapy Coming Soon Thanks to NIH & Foundation Research Funding

Posted by Rebecca Inch-Partridge on Mon, Oct 30, 2017

Scientists at UC San Francisco recently published the results of their Phase II Clinical Trial, which showed that an antihistamine restores nervous system function in patients with chronic multiple sclerosis (MS). In this landmark study, the antihistamine, clemastine fumarate, is the first medication that has been shown to reliably restore any brain function damaged by a neurological disease in human patients.

Read More

Tags: University of California San Francisco, Multiple Sclerosis, sell lab products, clinical trials, SFVS, UCSF, laboratory equipment suppliers, Lab Product Sales, UC San Francisco Parnassus, UCSF Mission Bay, BioResearch Product Faire, new scince buildings

Connect With Us   Like Us on Facebook   Follow Us on Twitter   See our latest photos!   Join Us on Google +   Find Us on LinkedIn   Pin our latest stories!

Subscribe to Company News